Výsledky vyhledávání - "J R, CALDWELL"

Autor: J. R. Caldwell, Richard A. Watson

Publikováno v: GECCO (Companion)

Model-building optimisation methods aim to learn the structure underlying a problem and exploit this to direct the exploration of solutions. This generally interleaves two processes: Generating samples (from the model), and updating the model (using

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a4f0549c1afa4e6ce32c09ea292a38a9
https://doi.org/10.1145/3067695.3076049

Zobrazit plný text záznamu

Surface treatment of polycarbonate films with amines

Autor: W. J. Jackson, J. R. Caldwell

Publikováno v: Journal of Polymer Science Part C: Polymer Symposia. 24:15-23

Bisphenol polycarbonates react with primary and secondary amines to form urethane groups by cleaving the molecular chain. The urethane group remains attached to a segment of the polymer molecule. If a diamine or polyamine is used, the polarity of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d8b512c9fe38048628be774844a71641
https://doi.org/10.1002/polc.5070240105

Zobrazit plný text záznamu

Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group

Autor: K D, Brandt, J A, Block, J P, Michalski, L W, Moreland, J R, Caldwell, P T, Lavin

Publikováno v: Clinical orthopaedics and related research. (385)

A prospective, multicenter, randomized, double-blind, controlled trial was conducted in 226 patients with knee osteoarthritis to evaluate the safety and efficacy of intraarticular injections of sodium hyaluronate. Patients were randomized to three we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::55c795e18e0be61234edc6e2ddcee75f
https://pubmed.ncbi.nlm.nih.gov/11302304

Zobrazit plný text záznamu

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group

Autor: G W, Cannon, J R, Caldwell, P, Holt, B, McLean, B, Seidenberg, J, Bolognese, E, Ehrich, S, Mukhopadhyay, B, Daniels

Publikováno v: Arthritis and rheumatism. 43(5)

To compare the clinical efficacy of rofecoxib, a specific inhibitor of cyclooxygenase 2 (COX-2), with that of diclofenac in patients with osteoarthritis (OA) and to evaluate the safety and tolerability of rofecoxib.We performed a randomized, double-b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8b5e37a30463b0b50334704e2e9904c2
https://pubmed.ncbi.nlm.nih.gov/10817549

Zobrazit plný text záznamu

Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis

Autor: L W, Moreland, D P, McCabe, J R, Caldwell, M, Sack, M, Weisman, G, Henry, J E, Seely, S W, Martin, C L, Yee, A M, Bendele, J L, Frazier, T, Kohno, M E, Cosenza, S A, Lyons, J M, Dayer, A M, Cohen, C K, Edwards

Publikováno v: The Journal of rheumatology. 27(3)

To evaluate the safety, immunogenicity, pharmacokinetics, and efficacy of intravenous administration of tumor necrosis factor binding protein (TNFbp) dimer in patients with rheumatoid arthritis (RA).This phase I/II study was a multicenter, randomized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cb14cf6c8b5f121be2b24a84abd07dc4
https://pubmed.ncbi.nlm.nih.gov/10743796

Zobrazit plný text záznamu

The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial

Autor: D T, Felson, M P, LaValley, A R, Baldassare, J A, Block, J R, Caldwell, G W, Cannon, C, Deal, S, Evans, R, Fleischmann, R M, Gendreau, E R, Harris, E L, Matteson, S H, Roth, H R, Schumacher, M H, Weisman, D E, Furst

Publikováno v: Arthritis and rheumatism. 42(10)

To evaluate the efficacy and safety of the Prosorba column as a treatment for rheumatoid arthritis (RA) in patients with active and treatment-resistant (refractory) disease.A sham-controlled, randomized, double-blind, multicenter trial of Prosorba ve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f88baa6c4147c19f02365dcfd29bf203
https://pubmed.ncbi.nlm.nih.gov/10524687

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání